Site icon Los Angeles Chronic Pain

Strategies To Assist with the Management of Pain (STAMP): All-Virtual Study for People with Chronic Lower Back Pain, Treated with Daily Opioid Medications 



FDA slates VR for lower back pain and fibromyalgia for expedited review |  MobiHealthNewsStrategies To Assist with the Management of Pain (STAMP): All-Virtual Study for People with Chronic Lower Back Pain, Treated with Daily Opioid Medications 


Enrollment will permanently close on May 31, 2021


Telehealth is the Future – and the Future has arrived! The STAMP study, which aims to help people manage Chronic Lower Back Pain (CLBP), was recently approved to become completely virtual, utilizing tele-health options, in light of the ongoing COVID-19 pandemic. The study is available to adults from across the U.S. through its all-virtual option! 


The STAMP study offers promise for adults with CLBP who are treated with daily opioids to better relieve pain, reduce disability, and improve quality of life. It compares the effects of two therapies, cognitive behavioral therapy and mindfulness meditation, on CLBP-related pain, function, and quality of life. Both therapies are delivered virtually over eight weekly group sessions. Participants receive one of these two therapies free of charge and, in addition, are reimbursed for their time and effort. The study is conducted by research teams at the University of Wisconsin (Madison, WI), Brigham and Women’s Hospital (Boston, MA), University of Utah (Salt Lake City, UT), and Pennsylvania State University (Hershey, PA).


 More details about the STAMP study can be found at the study (www.STAMPstudy.org) or the ClinicalTrials.gov (https://clinicaltrials.gov/ct2/show/NCT03115359) websites.  
 
Exit mobile version